Author: Fiona Craig

Cleveland-Cliffs (NYSE:CLF) saw its stock drop about 1.5% in premarket trading Wednesday after GLJ Research sharply lowered its rating on the company from “Buy” to “Sell,” slashing its price target to $3.91. The shift represents a dramatic turnaround by analyst Gordon Johnson, who openly acknowledged his January recommendation to buy the stock at $9.90 as…

Hyperfine, Inc. (NASDAQ: HYPR), the company behind the world’s first FDA-cleared portable MRI system powered by artificial intelligence – the Swoop® system – has received FDA approval for its latest software innovation, Optive AI™. This marks the tenth major software update for the Swoop® system and represents a significant advancement in image quality for ultra-low-field…

The major U.S. index futures on the Dow Jones, S&P and Nasdaq are currently pointing to a roughly flat open on Wednesday, with stocks likely to show a lack of direction following the rally seen in the previous session. Traders may be reluctant to make significant moves ahead of the release of earnings news from…

Columbus McKinnon Corporation (NASDAQ:CMCO) released its fiscal fourth-quarter results for 2025 on Wednesday, with revenue coming in below analyst expectations. Following the announcement, the company’s shares dropped 1.29% in pre-market trading. The manufacturer of material handling equipment reported adjusted earnings per share of $0.60, slightly above the $0.58 consensus. However, revenue totaled $246.9 million, missing…

Macy’s Inc (NYSE:M) has revised downward its full-year 2025 earnings and adjusted EBITDA margin guidance, citing the effects of tariffs, softer consumer discretionary spending, and intensified promotional competition. Nevertheless, the company’s first-quarter results surpassed analyst expectations. Following the report, Macy’s shares rose over 1% in premarket trading as of 11:07 GMT. The department store now…

Dick’s Sporting Goods (NYSE:DKS) delivered first-quarter results that exceeded expectations, driven by record sales and continued momentum in comparable store performance. Despite the strong report, shares dipped 0.6% following the announcement. For the quarter ending May 3, 2025, the retailer reported adjusted earnings per share of $3.37, surpassing analysts’ projections of $3.20. Revenue reached $3.17…

Brooge Energy Limited (NASDAQ:BROG) saw its stock soar by 70% after announcing a conditional agreement to sell its subsidiaries, BPGIC FZE and BPGIC Phase III FZE, to Gulf Navigation Holding PJSC (GulfNav). This strategic move is expected to significantly reshape Brooge’s business trajectory. Valued at roughly $884 million, the transaction includes around $125.3 million in…

Spero Therapeutics, Inc. (NASDAQ:SPRO) saw its stock soar by 240% after announcing highly encouraging results from its Phase 3 PIVOT-PO trial, conducted in collaboration with development partner GSK plc (LSE/NYSE: GSK). The trial assessed tebipenem HBr, an investigational oral carbapenem antibiotic aimed at treating complicated urinary tract infections (cUTIs). The study, which enrolled 1,690 patients,…

Abercrombie & Fitch Co. (NYSE:ANF) shares surged 25% in premarket trading Wednesday after reporting first-quarter results that exceeded earnings expectations, despite a slight revenue shortfall. The retailer posted adjusted earnings per share of $1.59, topping the $1.33 consensus by $0.26. Revenue reached $1.06 billion – just under the $1.08 billion forecast – but still marked…

Boston Scientific (NYSE:BSX) shares fell 4% after the company announced it will discontinue global sales of its ACURATE neo2 and ACURATE Prime Aortic Valve Systems. The decision follows discussions with regulatory agencies that resulted in stricter clinical and compliance requirements. On May 28, 2025, the company said the heightened regulatory demands would require resources and…